Review
Open access
Jul 2026
Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation
Cancer remains a major global health challenge, with conventional therapies often limited by toxicity and insufficient efficacy. Oncolytic virotherapy has emerged as a promising immunotherapeutic approach, utilizing genetically engineered viruses to selectively target and destroy cancer cells while stimulating anti-tum...
Nada Almarghalani, M. Ganash, Mona G. Alharbi et al.
· Frontiers in Oncology · 0 citations